Why Delta Air Lines Stock Is Moving

Delta Air Lines, Inc. (NYSE: DAL) shares are trading higher by 2% to $36.44 Wednesday morning.

Delta Air Lines, Inc. (NYSE:DAL) shares are trading higher by 2% to $36.44 Wednesday morning. Shares of airline stocks have been volatile this week amid the Israel-Hamas conflict, which has caused travel uncertainty and lead to U.S. airlines suspending flights to Israel.

U.S. airlines have suspended flights to Israel in response to rocket attacks by Hamas, the Palestinian militant organization in control of the Gaza Strip, resulting in casualties and numerous individuals held captive in Gaza.

See Also: Hezbollah Missiles Intensify Israel Conflict; Yellen Says More Iran Sanctions Possible

When airlines suspend flights to a specific destination due to conflict or security concerns, it can lead to a significant loss of revenue for those airlines. In this case, when Delta Air Lines or other U.S. airlines suspend flights to Israel, it means they are losing out on the revenue generated from those routes. This can negatively impact their financial performance and, consequently, their stock price.

Geopolitical conflicts can also have broader economic impacts, which can affect the overall health of the airline industry. These impacts may include changes in consumer sentiment, fluctuations in oil prices and disruptions in global trade, all of which can influence airline stocks.

See Also: Biden’s Administration Bolsters Israel’s Defense As First Shipment Of Advanced Weaponry Lands

According to data from Benzinga Pro, Delta Air Lines has a 52-week high of $49.81 and a 52-week low of $28.21.

Total
0
Shares
Related Posts
Read More

The Party Is On: Investors Are Piling Into Risk Assets And Saying No To Treasuries

Stocks have been due for a rally, and coinciding with the historically strong month of October, the broad market S&P 500 has climbed nearly 5% over the last month, after falling 9% in September. Is bullish sentiment back? ETF flows over the past week suggest the answer is yes.

GOOG

Read More

Toronto Weed Producer Seals Deal For Over $100M In Annual Revenue As RWB Finalizes Aleafia Health Buyout

Red White & Bloom has completed its acquisition of Aleafia Health and its subsidiaries, RWB Canada has obtained Aleafia Health's intellectual property assets and purchased shares in the companies Emblem Cannabis, Aleafia Retail and Canabo Medical. It acquired 9.4% of One Plant from Aleafia and obtained shares, an 86-acre cultivation site in Port Perry, Ontario and a 65,000sq ft cultivation, processing and packaging facility in Paris, Ontario. In a press release RWB CEO Bradley R. Rogers said the acquisition "provides a clear and near-term path to combine our teams while rolling up strategic assets across Canada." RWB anticipates generating CA$140m ($105m) of annualized revenue across north American retail and distribution channels from the combination, with Colby De Zen, president of RWB, forecasting "annual synergies exceeding CA$12 million".

ALEAF